Showing results (281-290 of 415) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|September 1, 1986
Synthesis of anthraquinonyl glucosaminosides and studies on the influence of aglycone hydroxyl substitution on superoxide generation, DNA binding, and antimicrobial propertiesH N Abramson, J W Banning, J P Nachtman, et al.
The Journal of Psychotherapy Practice and Research|July 1, 1997
Effectiveness of a training program for enhancing therapists' understanding of the supportive-expressive treatment model for breast cancer groupsC Classen, S Abramson, K Angell, et al.
Ophthalmology|May 1, 1990
Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndromeJ G Gross, S A Bozzette, W C Mathews, et al.
The Journal of Biological Chemistry|September 5, 1997
Differential targeting of nicotinic acetylcholine receptors by novel alphaA-conotoxinsR Jacobsen, D Yoshikami, M Ellison, et al.
Leukemia & Lymphoma|January 8, 2013
Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 studyJeremy S Abramson, Ronald W Takvorian, David C Fisher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2010
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphomaJ A Barnes, A S LaCasce, K Zukotynski, et al.
Osteoarthritis and Cartilage|January 18, 2019
Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritisY He, T Manon-Jensen, L Arendt-Nielsen, et al.
Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.
Leukemia & Lymphoma|May 11, 2019
Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemiaJacob D Soumerai, Matthew S Davids, Lillian Werner, et al.
Annals of the Rheumatic Diseases|November 29, 2013
The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?M A Karsdal, A C Bay-Jensen, R J Lories, et al.
Pageof 42